Isolation of Primary Mouse Pulmonary Microvascular Endothelial Cells and Generation of an Immortalized Cell Line to Obtain Sufficient Extracellular Vesicles

Xu Liu, Feiping Xia, Xiao Wu, Ying Tang, Lu Wang, Qin Sun, Xue Ming, Yahui Li, Ling Liu, Fengmei Guo, Yi Yang, Haibo QiuFrontiers in Immunology 2021 · DOI

TL;DR

Researchers have developed a robust, high-purity protocol for isolating primary mouse pulmonary microvascular endothelial cells (PMECs) and immortalizing them using an SV40 lentivirus. This new cell line (iMPMECs) maintains the essential characteristics of primary cells while producing nearly 20 times more extracellular vesicles (EVs), providing a scalable model for studying lung inflammation and physiology.

What Problem Does This Paper Address?

Pulmonary microvascular endothelial cells (PMECs) are the "gatekeepers" of the lung, forming the critical barrier between blood and air. They play a starring role in diseases like pneumonia, sepsis, and ARDS. Recently, scientists have become fascinated by the extracellular vesicles (EVs) these cells secrete—tiny cargo ships that carry molecular signals throughout the body.

However, studying mouse PMECs is notoriously difficult. Traditional "positive selection" methods (pulling the cells out using specific markers) often yield very few cells that stop dividing almost immediately (senescence). Furthermore, these samples are frequently contaminated by aggressive fibroblasts. Because primary cells produce so few EVs before they die out, it has been nearly impossible to gather enough material for high-quality experiments.

Methods

The authors present a two-stage solution: a refined isolation protocol followed by viral immortalization.

  1. Negative Selection Isolation: Instead of grabbing the PMECs directly, the team used magnetic beads to "trash" the cells they didn't want. They depleted leukocytes (CD45+), fibroblasts (CD90.2+), and epithelial cells (CD326+). This avoids the mechanical stress and potential activation that occurs when you pull on the target cells directly.
  2. Cloning Cylinders: To ensure 100% purity, they used physical cloning cylinders to pick and expand only the colonies that showed the classic "cobblestone" endothelial morphology.
  3. Immortalization: They tested several viral vectors and found that a Lenti-SV40 virus was the most effective at extending the cells' lifespan without ruining their "endothelial-ness."
  4. Characterization: The team used a battery of tests to prove the new iMPMEC line was legitimate, including:
  5. Phenotyping: Flow cytometry for markers like CD31 and CD144.
  6. Functional Assays: Dil-AcLDL uptake and Matrigel tube formation (angiogenesis).
  7. EV Analysis: Transmission electron microscopy (TEM) for shape, Nanoparticle Tracking Analysis (NTA) for size, and Western blotting for protein markers (CD63, Alix, etc.).

Datasets

As a methodology paper in immunology, this study does not use computational datasets. Instead, it utilizes biological "benchmarks":

  • Primary Mouse PMECs (pMPMECs): Isolated from neonatal mouse lung tissue.
  • Immortalized Mouse PMECs (iMPMECs): The newly generated cell line.
  • LPS-induced inflammation model: Used to validate that both cell types respond identically to inflammatory stimuli (upregulating VCAM-1 and ICAM-1).

Key Insights and Ideas

  • Negative Selection is Superior: By removing "contaminants" rather than pulling on the target cells, the researchers obtained healthier primary cultures with higher viability.
  • The SV40 Advantage: While other viruses (like hTERT or HPV-16) caused the cells to look "sick" or stop growing (senescence), the SV40-transduced cells maintained a stable, proliferative phenotype over many passages.
  • EV Fidelity: Perhaps the most important finding is that while iMPMECs produce 20x more EVs than primary cells, the quality of those EVs (size distribution and protein markers) remains virtually identical. This validates the immortalized line as a high-yield "factory" for EV research.
  • Functional Consistency: The iMPMECs didn't just look like endothelial cells; they acted like them, successfully forming capillary-like tubes on Matrigel and responding to inflammatory triggers (LPS) just like their primary counterparts.

Key Results

  • High Purity: The isolation method achieved >94% purity for primary cells and >97% purity for the immortalized line (based on CD31 expression).
  • Massive EV Yield: iMPMECs produced approximately 1,222 EVs per cell, compared to only 40 EVs per cell from primary cultures.
  • Inflammatory Response: Both cell types showed a significant increase in vascular permeability and protein expression (VCAM-1, ICAM-1) when treated with LPS, proving the immortalized line is a valid model for ARDS research.
  • Marker Validation: Both cell-derived EVs were positive for standard markers (CD63, CD81, Alix, Tsg-101) and negative for the contamination marker GM130.

Limitations and Future Work

The authors acknowledge that while SV40 is excellent for expansion, any immortalization process involves altering the cell's genetic landscape, which could theoretically affect niche signaling pathways not tested here.

Future work will likely involve using these "EV factories" to perform deep sequencing (RNA-seq) or proteomics on the vesicles themselves to see exactly what messages they are carrying during lung injury. This protocol opens the door for other researchers to stop struggling with low cell yields and start focusing on the functional roles of EVs in pulmonary disease.

Summary updated

Abstract

Pulmonary microvascular endothelial cells (PMECs) and the extracellular vesicles (EVs) derived from PMECs participate in maintaining pulmonary homeostasis and mediating the inflammatory response. However, obtaining a high-purity population of PMECs and their EVs from mouse is still notoriously difficult. Herein we provide a method to isolate primary mouse PMECs (pMPMECs) and to transduce SV40 lentivirus into pMPMECs to establish an immortalized cell line (iMPMECs), which provides sufficient quantities of EVs for further studies. pMPMECs and iMPMECs can be identified using morphologic criteria, a phenotypic expression profile (<i>e</i>.<i>g</i>., CD31, CD144, <i>G. simplicifolia</i> lectin binding), and functional properties (<i>e</i>.<i>g</i>., Dil-acetylated low-density protein uptake, Matrigel angiogenesis). Furthermore, pMPMEC-EVs and iMPMEC-EVs can be identified and compared. The characteristics of pMPMEC-EVs and iMPMEC-EVs are ascertained by transmission electron microscopy, nanoparticle tracking analysis, and specific protein markers. iMPMECs produce far more EVs than pMPMECs, while their particle size distribution is similar. Our detailed protocol to isolate and immortalize MPMECs will provide researchers with an <i>in vitro</i> model to investigate the specific roles of EVs in pulmonary physiology and diseases.
BibTeX
@inproceedings{liu2021isolation,
  author = {Xu Liu and Feiping Xia and Xiao Wu and Ying Tang and Lu Wang and Qin Sun and Xue Ming and Yahui Li and Ling Liu and Fengmei Guo and Yi Yang and Haibo Qiu},
  title = {{Isolation of Primary Mouse Pulmonary Microvascular Endothelial Cells and Generation of an Immortalized Cell Line to Obtain Sufficient Extracellular Vesicles}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.759176},
}
Figure